2026 PLENARY SESSION

TUESDAY, AUGUST 25 | 11:30 – 11:40 AM

Plenary Keynote Presentation: Outlook for IVDs

Courtney H. Lias, PhDCourtney H. Lias, PhD, Director, OHT7: Office of in vitro Diagnostic Devices, United States Food and Drug Administration (FDA)

TUESDAY, AUGUST 25 | 11:40 AM – 12:15 PM

Plenary Fireside Chat: Regulatory Outlook for Diagnostics

Brian P. Carey, JDPANEL MODERATOR:
Brian P. Carey, JD, Partner, Hogan Lovells US LLP


Courtney H. Lias, PhDPANELISTS:
Courtney H. Lias, PhD, Director, OHT7: Office of in vitro Diagnostic Devices, United States Food and Drug Administration (FDA)


Jai Pandey, PhDJai Pandey, PhD, Head, Global Device Regulatory IVD/CDx and Digital Health, Sanofi


Zach Rothstein, JDZach Rothstein, JD, Executive Director, AdvaMedDx


Susan Van MeterSusan Van Meter, President, American Clinical Laboratory Association


Sheila D. Walcoff, JDSheila D. Walcoff, JD, Founding Principal & CEO, Goldbug Strategies LLC


TUESDAY, AUGUST 25 | 12:15 – 1:05 PM

Plenary Fireside Chat: Business of Diagnostics and Future Outlook

Phillips KuhlPANEL MODERATOR:
Phillips Kuhl, Founder & Chairman, Cambridge Healthtech Institute


Christine C. GinocchioPANELISTS:
Christine C. Ginocchio, PhD, MT(ASCP), CMO, Qiagen


Taylor Jensen, PhDTaylor Jensen, PhD, Vice President, Head of Science, Oncology, Labcorp


Elissa QuinnElissa Quinn, Medical Director, Cancer Screening & Early Detection, AstraZeneca


Ipsita G. SmolinskiIpsita G. Smolinski, MBA, Managing Director, Capitol Street; Faculty, Georgetown University


final-agenda

2026 Conference Programs